Clinical trial
MAGNOLIA: Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
NCT02952001 is registered in ClinicalTrials.gov with Clearside Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MAGNOLIA: Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
- Lead sponsor
- Clearside Biomedical, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- May 22, 2018
- Enrollment
- 33 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.